Daniel Lee Flynn, Chief Scientific Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 143,185 shares at $48.01 ($6.9M) on 2019-11-11, disclosed to the SEC on 2019-11-13.
Open-market sale of $6.9M DCPH by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DCPH | SELL | 2023-01-19 | $102K | — | Filing → |
| DCPH | SELL | 2022-06-21 | $19K | — | Filing → |
| DCPH | SELL | 2022-02-18 | $12K | — | Filing → |